WASHINGTON – The Association for Accessible Medicines (AAM) and its board of directors announced the promotion of Christine Simmon to executive vice president, Policy and Strategic Alliances. She also serves as executive director of the Biosimilars Council, the AAM subsidiary that advocates for greater access for patients to biosimilar medicines. She is the executive sponsor of Women in Health Policy (WiHP), a group powered by AAM promoting professional effectiveness and development.

Dan Leonard

Simmon has been with the association for 13 years, first from 2002 to 2006, rejoining in 2012. She has held leadership roles in the policy, communications, international, legal, federal government affairs, alliances and meetings departments over the course of her tenure, and has been an integral part of the organization’s growth. She is a lawyer by training and her prior career experience includes senior positions in the health plan, pharmacy benefit management and retail pharmacy industries. 

“The AAM board and I are pleased to elevate Christine to executive vice president, where she leads efforts to strengthen long-term sustainability of the generics and biosimilars industry to achieve our mission of patient access,” said Dan Leonard, AAM president and CEO. “Her deep knowledge of the sector, strategic vision, member-centric approach and successful team-building have proven invaluable to the industry’s leadership and her data-driven approach to policy has contributed to AAM’s track record of successful advocacy for pharmaceutical competition and improved market access.”

She has led policy and data development in key areas such as access to generics in Medicare and Medicaid and has overseen the expansion of strategic alliance building to include patient and provider organizations.  She reports to Dan Leonard.